NCT01320852

PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

PET Scan as a Screening Tool for Liver Transplant in Patients With HCC

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.

Conditions

• Hepatocellular Carcinoma

Interventions

Type	Name	Description
OTHER	PET Scan	All patients will have a PET scan as part of their pre-transplant assessment

Timeline

• Start date: 2010-12-01
• Primary completion: 2013-09-01
• Completion: 2013-10-01
• First posted: 2011-03-23
• Last updated: 2013-10-25

Locations

1 site across 1 country: Canada